Evan Fall Protection

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.

RLM Communications Inc, a privately owned Service Disabled Veteran Owned Small Business, specializes in delivering mission-critical communications solutions for government agencies. With a focus on advanced technology integration, the company is recognized for its expertise in IT systems, cybersecurity, and audiovisual solutions, ensuring reliable and secure communications in complex environments. Led by President and CEO Randy L. Moore, RLM Communications is an award-winning defense contractor with a commitment to meeting stringent government security protocols. The company boasts a highly accredited team, including PMP-certified program managers and industry-leading instructors, dedicated to providing tailored solutions and ongoing support for its clients' unique needs. Generated from the website